A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney Cancer
Clinical trial NCT01525017 · COMPLETED
Trial details
- NCT number
- NCT01525017
- Sponsor
- Mendus
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2013-12-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.